|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Click here to see latest analysisDARA BioSciences, Inc. reports financial results for the quarter ended September 30, 2015.We analyze the earnings along side the following peers of DARA BioSciences, Inc. – Puma Biotechnology, Inc., Cyclacel Pharmaceuticals, Inc., Oculus Innovative Sciences, Inc., Cardinal Health, Inc., AMAG Pharmaceuticals, Inc., OncoMed Pharmaceuticals, Inc., Array BioPharma Inc. and AmerisourceBergen […] (Read more...) The post DARA BioSciences, Inc. Earnings Q3, 2015 appeared first on CapitalCube.
DARA BioSciences, Inc. reports preliminary financial results for the quarter ended June 30, 2015.DARA BioSciences, Inc. (DARA-US) is one of the first companies amongst its peer group to announce earnings for this period.HighlightsSummary numbers: Revenues of USD 0.99 million, Net Earnings of USD -2.68 million, and Earnings per Share (EPS) of USD -0.14.Gross margins widened […] (Read more...) The post DARA BioSciences, Inc. Earnings Q2, 2015 appeared first on CapitalCube.